InventisBio is a clinical stage biotech company with two drugs approved and three candidates in clinical trials with the most advanced one in a phase 3 registration trials in China. We are focusing on areas of oncology, metabolic and autoimmune diseases to address unmet medical needs. The company was founded by a group of scientists with extensive R&D and management experience in global pharmaceutical companies. It is headquartered in Shanghai Pudong with operations in Beijing and US (New Jersey) as well.
